Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

Newsletter
  July 19, 2008  
  Volume IX, Issue 51  
Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

To OTC Journal Members:
 

  Comments in the BLOG  

For all of you who were following the trading strategy I laid out in last weekend's edition for shorting large caps into earnings releases, you probably have figured out by now that I have pretty much abandoned that idea. The Daily BLOGs have contained no short term trading ideas.

I watched a few of the stocks in the table trade on Monday and Tuesday after earnings, and I decided it was too much of a crap shoot to pursue. The analysts have pretty much sabotaged this strategy by ramping the earnings estimates so low companies are not having much trouble beating them. There is more bad news priced into stocks than the actual earnings would suggest. Therefore, companies are generally beating. They only sell off if the company gives negative warnings about the future. It was a nice idea, but I know when to abandon a strategy that doesn't look like it has potential.

On a separate note, I'm announcing the launch of a whole new OTC Journal site in about the next 10 days. The new site will be considerably more user friendly. It will be far more pleasing to the eye and easier to navigate. It also has a lot of video content. You will be able to review 18 different short video clips on various investing principles. I think you'll like it. More as we get closer to launch day.
 

The SEC's Selective Short Protection - It Makes Me Want To Vomit

Small and microcap companies have been complaining for years about the abuses built into the system that favor "illegal naked short selling". For those of you unfamiliar with the practice, let's go over some basics about short selling.

When you sell a stock short, you do the sell transaction first, and the buy transaction second. You sell, and hope to buy back later at a lower price. Instead of "buy low and sell high", it's "sell high and buy low". When you buy the shares back, it is known as "covering your short".

In order to trade in this manner, us regular, every day investors have to get our brokerage to "locate" shares, borrow them, and then allow us to execute the short sale. Market makers are allowed by regulation to short stocks without borrowing them as part of their normal trading practices.

I think short selling is great, and anyone should be allowed to short a stock who has the capital. 

Illegal naked short selling has been the subject of much complaining and consternation by many public companies and interested parties for many years. This occurs when a short sell is executed without a legitimate borrow first. Institutional investors are allowed to do this on a regular basis as a course of business. The fact that it is allowed is 100% the fault of the SEC's lax attitude towards this practice.

Prime brokers generate millions in fees on the trading side. The DTC system, the people who keep track of the street name stock at your brokerage firm, also collects millions in fees for "open fail to delivers"- shares of stocks that have been sold, but the trades never settled since the seller couldn't deliver.

The whole practice is the subject of a giant class action suit by the guys who got big tobacco and the asbestos industry. In essence, as many have pointed out in the past, illegal naked short selling allows sellers to actually create "counterfeit shares"- shares that don't exist, and sell them to create excess supply.

This past week, the Christopher Cox, the Chairman of the SEC, was interviewed on CNBC, and after watching the interview I was literally ready to vomit.

Early in the week the SEC announced it was invoking a "Ban on Illegal Naked Short Selling". Wow I thought to myself. If there was one good thing that would come out of this Bear Market, having the SEC get rid of illegal naked short selling by closing up the loopholes in the DTC System would be my #1 choice.

Alas, the level of stupidity, and the unbelievable hypocrisy of these guys just blew my mind. The SEC is going to monitor and stop illegal naked short selling, but only on 17 designated financial stocks that trade gazzilions of shares everyday, and have been beaten into oblivion by the bears. 

Christopher Cox got up on CNBC, and in an interview actually stated that Illegal Naked Short Selling was, in fact, not illegal. Technically, it might simply be a violation of SEC regs- and it happens due to a series of loopholes in the system that allow it to happen.

He stated they were invoking the special power to ban the naked short selling in 17 bank stocks for 30 days, but that it would be far too difficult and inefficient to ban naked short selling across the board on every stock. 

Dear Mr. Chairman- please answer this question for me? if you can ban illegal naked short selling on 17 of the most heavily traded financial stocks- stocks that trade literally hundreds of millions of shares everyday and are traded by hundreds of hedge funds and other institutions, why can't you ban illegal naked short selling on a $.50 stock that only trades 100,000 shares everyday. Wouldn't that be far easier to track?

About 15 minutes after the interview, CNBC trotted out Cramer. This guy can certainly have his moments, and this was one of them. I applaud his courage. He called out the shear stupidity of the SEC stance on this issue, and was actually waving a copy of the statute that requires the SEC to regulate the proper settlement of trades. 

Ladies and gentlemen, unfortunately, this is your government regulators at their very worst. This whole thing is one big transparent gimmick to prevent Fanny and Freddie from completely melting down to nothing, and is selective enforcement at its worst. 

Over the past couple of years the SEC has implemented some rule changes favoring small companies that I applaud. Rule 405, which limits the number of share small companies can include in a registration statement, was great for financing small companies. The change in Rule 144 and the relative ease of the registration process under the current SEC is a welcome change for smaller companies and enhances their ability to raise capital in a way that is not a detrimental to stock values.

However, this ban on illegal naked short selling for a few companies is a real slap in the face for investors on the long side. A personal thank you goes out the Jim Cramer for pointing out the shear hypocrisy. 

It makes me want to vomit. If it's right for 17 financials, it's right for all stocks. Chairman Cox suggested the commission could look into some "rule changes", which of course they won't do. 

SEC- do your job and make the playing field fair for all investors. If huge institutions can naked short stocks without legitimate borrows, let me do it too. Make it the rule. If not, enforce the existing rules.

All they need to do is enforce the existing rules. That's it. 

Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com
 

  Subscribe  

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Subscribe Here

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

  Refer A Friend  

If you find the OTC Journal informative and profitable, please forward our newsletter alert service to like-minded friends and associates who share similar market interests.


  Ensure Newsletter Delivery  

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition. 

Disclaimer
The OTC Journal Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features. Likewise, this newsletter is owned by MarketByte, LLC. To the degrees enumerated herein, this newsletter should not be regarded as an independent publication.

Go Here to view our compensation on every company we have ever covered, or visit the following web address: http://www.otcjournal.com/disclosure/compensation/section/profile/ for our full profiles and http://www.otcjournal.com/disclosure/compensation/section/alert/ for Trading Alerts.

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte, LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

The Trustee of the MarketByte, LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Longview Fund. Longview ocassoinally refers companies to MarketByte, LLC for possible coverage by one of the MarketByte, LLC publications, which publications include the OTC Journal Newsletter. Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Longview owns any shares in the companies that it refers to MarketByte, LLC. The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte, LLC client companies. 

The profiles, critiques, and other editorial content of the OTC Journal may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.COM.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID: Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.


You can unsubscribe from this list at any time by Clicking Here. If you are having difficulty removing yourself or wish to change your address please go to http://www.otcjournal.com/opt/?.

 

Newsletter
Editions
RSS Subscribe

Market Summary
Dow 11430.21 +12.78 (+0.11%)
Nasdaq 2380.38 -8.70 (-0.36%)
Russell 2K 725.25 -6.35 (-0.87%)
S&P 500 1277.72 +3.18 (+0.25%)
S&P 100 588.89 +1.24 (+0.21%)
Quotes are delayed 20 minutes.

® 2008 OTC Journal